Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

J App Pharm Sci. 2021; 11(7): 172-182

Utilization and expenditure on long-acting insulin analogs among selected middle-income countries with high patient co-payment levels: Findings and implications for the future

Mainul Haque, Salequl Islam, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Sylvia Opanga, Zubair Mahmood Kamal, Farhana Akter, Brian Godman.

The number of patients with diabetes and associated complications is rising across countries including patients requiring insulin to control their diabetes. Hypoglycemia combined generally with poor control adds to the burden of diabetes. Long-acting insulin analogs were developed to reduce hypoglycemia, including nocturnal hypoglycemia, and enhance adherence, which can be a problem. These benefits have resulted in their increased use among high and high-middle income countries, which is continuing. However, concerns in middle and lower-income countries as insulin analogs are considerably more expensive than standard insulins. Biosimilars can reduce their costs. Consequently, it is important to ascertain current usage and prices of analogs across middle-income countries with high patient co-payment levels to provide future direction. Overall, limited use of insulin glargine in Kenya, up to 3.6% of total insulins in one leading hospital with prices up to 3.4 fold higher than standard insulins. Overall, limited use of insulin glargine among hospitals in Northern Nigeria and in pharmacies again due to high prices. Appreciably higher use of long-acting insulin analogs in Bangladesh enhanced by low cost biosimilars with increasing competition. Increased competition enhanced by local production can lower biosimilar costs enhancing future use of insulin glargine to the benefit of all diabetes patients requiring insulin.

Key words: Affordability, Bangladesh, diabetes, Kenya, long-acting insulin analogues, Nigeria

Similar Articles

The impact of the COVID-19 pandemic on the poor: Insights from the Hrishipara diaries.
Rönkkö R, Rutherford S, Sen K
World development. 2022; 149(): 105689

Synergistic effect of extrusion and polyphenol molecular interaction on the short/long-term retrogradation properties of chestnut starch.
Zeng X, Zheng B, Xiao G, Chen L
Carbohydrate polymers. 2022; 276(): 118731

Insufficient ventilation led to a probable long-range airborne transmission of SARS-CoV-2 on two buses.
Ou C, Hu S, Luo K, Yang H, Hang J, Cheng P, Hai Z, Xiao S, Qian H, Xiao S, Jing X, Xie Z, Ling H, Liu L, Gao L, Deng Q, Cowling BJ, Li Y
Building and environment. 2022; 207(): 108414

Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299

Regenerative Periodontal Therapy in Intrabony Defects and Long-Term Tooth Prognosis.
Stavropoulos A, Bertl K, Sculean A, Kantarci A
Dental clinics of North America. 2022; 66(1): 103-109

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites